MDCG Publishes Revision 2 of EMDN Guidance (MDCG 2021-12 Rev.2)

In April 2026, the Medical Device Coordination Group (MDCG) published Revision 2 of MDCG 2021-12, providing updated FAQs on the European Medical Device Nomenclature (EMDN) .

The document clarifies the use, structure, and maintenance of EMDN under Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR).

Role of EMDN

According to the MDCG document, the EMDN:

  • Supports the functioning of EUDAMED

  • Is used by manufacturers for device registration, linked to the UDI-DI

  • Is used in:

    • Technical documentation

    • Notified Body sampling

    • Post-market surveillance

    • Vigilance and post-market data analysis

The nomenclature is available free of charge and accessible to all stakeholders.

Structure of the nomenclature

The EMDN is based on a seven-level hierarchical structure, including:

  • Categories (first level)

  • Groups (second level)

  • Types (third level and further sublevels)

Each code is alphanumeric and linked to a term describing the device.

EMDN code assignment

The document states that manufacturers:

  • Must assign the most granular (lowest-level) code available

  • Should assign one code per UDI-DI, unless multiple intended purposes apply

Where no appropriate code exists, the code extension “99 – Other” may be used.

Code extensions “90” and “99”

The MDCG clarifies that:

  • “99 – Other” represents a terminal level and may be used for UDI-DI assignment

  • “90 – Various” is not a terminal level and cannot be used for UDI-DI registration

Multiple EMDN codes

Multiple codes may be assigned in specific cases, including:

  • Devices with multiple intended purposes

  • Devices falling under Category X (Annex XVI products without an intended medical purpose)

  • Devices with both medical and non-medical intended purposes

No prioritisation between assigned codes is required.

Annual update procedure

The MDCG describes an annual EMDN update process, including:

  • Publication of updates on the European Commission website

  • Availability of documentation describing changes compared to previous versions

  • No direct notification to users on implemented changes

A 15 working day deadline is established for responding to clarification requests during the review process.

Obsolete and split codes

The document specifies that:

  • Obsolete codes remain visible in EUDAMED for at least 5 years, but cannot be used for new registrations or updates

  • Split codes remain visible but are no longer available for registration

  • Archives of obsolete and split codes are maintained and made publicly available

Updates to registrations and documentation

Manufacturers and notified bodies are expected to:

  • Reflect EMDN changes in:

    • EUDAMED registrations

    • Certificates

    • Declarations of Conformity

  • Implement updates at the latest before the next annual surveillance audit following the update cycle

Read the full document below.

Anterior
Anterior

CMS Proposes New UDI Measure Under Medicare Interoperability Program

Próximo
Próximo

ENISA Publishes National Capabilities Assessment Framework (NCAF) 2.0 – 2026 Edition